SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 23.97 |
Enterprise Value ($M) | 21.20 |
Book Value ($M) | 26.59 |
Book Value / Share | 1.21 |
Price / Book | 0.90 |
NCAV ($M) | 23.90 |
NCAV / Share | 1.09 |
Price / NCAV | 1.00 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.69 |
Return on Assets (ROA) | -0.51 |
Return on Equity (ROE) | -0.63 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 9.71 |
Current Ratio | 9.71 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 27.11 |
Assets | 29.80 |
Liabilities | 3.21 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 9.75 | 1.48 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
70,102 | 235,828 | 29.73 | |
19,046 | 115,440 | 16.50 | |
15,017 | 77,723 | 19.32 | |
40,663 | 116,585 | 34.88 | |
85,303 | 372,705 | 22.89 | |
(click for more detail) |
Similar Companies | |
---|---|
ELDN – Eledon Pharmaceuticals, Inc. | ELTX – Elicio Therapeutics, Inc. |
ELUT – Elutia Inc. | ENSC – Ensysce Biosciences, Inc. |
ENTO – Entero Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io